
John Crable
Articles
-
Mar 18, 2024 |
cnbc.com | Annika Kim Constantino |John Crable |Julie Stich
Victoria Klesty | ReutersIn the U.S., Wegovy is no longer just for weight loss. Some employers and other health plans are still reluctant to cover Wegovy due to its hefty $1,350 monthly price tag, which they say could significantly strain their budgets. They also have other questions, such as how long patients actually stay on the treatment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →